Swedbank AB Grows Stock Position in Astera Labs, Inc. $ALAB

Swedbank AB increased its position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 76.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned 78,140 shares of the company’s stock after purchasing an additional 33,940 shares during the quarter. Swedbank AB’s holdings in Astera Labs were worth $12,999,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the period. State Street Corp raised its position in shares of Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after buying an additional 195,992 shares during the period. Amundi raised its position in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Value Aligned Research Advisors LLC raised its position in shares of Astera Labs by 16.7% during the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after buying an additional 197,320 shares during the period. Finally, BNP Paribas Financial Markets increased its holdings in Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

ALAB has been the subject of several research reports. Susquehanna lifted their target price on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Barclays lifted their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Finally, TD Cowen lifted their target price on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Check Out Our Latest Stock Report on ALAB

Astera Labs Stock Up 3.9%

NASDAQ:ALAB opened at $318.72 on Wednesday. The company has a fifty day simple moving average of $178.09 and a two-hundred day simple moving average of $161.43. The company has a market cap of $54.63 billion, a price-to-earnings ratio of 215.35, a price-to-earnings-growth ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $321.99.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it plans to showcase its AI infrastructure connectivity portfolio, including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event should boost visibility with analysts, customers, and ecosystem partners. Article Title
  • Positive Sentiment: Recent coverage highlighted ALAB’s strong stock momentum and cited bullish analyst views, which appears to be reinforcing investor enthusiasm for the company’s AI networking and semiconductor growth story. Article Title
  • Neutral Sentiment: Astera Labs was downgraded by Northland Securities from outperform to market perform, which could temper some of the recent optimism but does not by itself indicate a major deterioration in the business outlook.
  • Negative Sentiment: Insider selling continues to be notable, including a large COO sale under a 10b5-1 plan and a smaller sale by the general counsel. While preplanned, heavy insider selling can weigh on sentiment because it may suggest executives are taking profits after the stock’s sharp run-up.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. This trade represents a 36.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,316,257 shares of company stock worth $474,860,636. Corporate insiders own 12.50% of the company’s stock.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.